These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8991040)

  • 41. Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting.
    Baciewicz FA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2108-9; author reply 2109. PubMed ID: 14688746
    [No Abstract]   [Full Text] [Related]  

  • 42. [Skin necrosis induced by heparin: apropos of 2 cases].
    Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
    Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
    [No Abstract]   [Full Text] [Related]  

  • 43. Anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; Kox WJ; Spies C
    Contrib Nephrol; 2004; 144():308-16. PubMed ID: 15264419
    [No Abstract]   [Full Text] [Related]  

  • 44. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Apr; 99(4):776-8. PubMed ID: 18392337
    [No Abstract]   [Full Text] [Related]  

  • 45. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
    Kelton JG; Arnold DM; Bates SM
    N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
    [No Abstract]   [Full Text] [Related]  

  • 46. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 47. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Jul; 373(3):252-61. PubMed ID: 26176382
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
    Gilmore G; Thom J; Baker RI
    Thromb Haemost; 1996 Feb; 75(2):372-3. PubMed ID: 8815593
    [No Abstract]   [Full Text] [Related]  

  • 49. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 50. [Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
    Brémaud M; De Maistre E; Junke E; Guerci A; Lalot JM; Longrois D; Lecompte T; Meistelman C
    Ann Fr Anesth Reanim; 2004 Feb; 23(1):50-5. PubMed ID: 14980323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Danaparoid (Orgaran) as an antiocoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics)].
    von Lüpke U; Marx A; Tessmann R; Lindhoff-Last E
    Anaesthesist; 2001 Jan; 50(1):26-31. PubMed ID: 11220255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin induced thrombocytopenia. Experiences in 12 heart surgery patients.
    Sodian R; Loebe M; Gorman KF; Riess H; Hetzer R
    ASAIO J; 1997; 43(5):M430-3. PubMed ID: 9360077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E; Bauersachs R
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].
    Tardy-Poncet B; Reynaud J; Tardy B; Mahul P; Mismetti P; Beraud AM; Rebaud MA; Bayon M; Guyotat D
    Presse Med; 1996 May 4-11; 25(16):751-5. PubMed ID: 8692750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Danaparoid is not a low-molecular-weight heparin.
    Nicholson CD; Meuleman DG; Magnani HN; Egberts JF; Leibowitz DA; Spinler SA; Cziraky MJ
    Am J Hosp Pharm; 1994 Aug; 51(16):2049-50. PubMed ID: 7526686
    [No Abstract]   [Full Text] [Related]  

  • 56. Delivery of a healthy child 30 weeks after resuscitation for thromboembolism and treatment with danaparoid: 5-year follow up.
    Weilbach C; Rahe-Meyer N; Raymondos K; Piepenbrock S
    J Perinat Med; 2006; 34(6):505-6. PubMed ID: 17140305
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 59. Invited commentary.
    Francis JL
    Ann Thorac Surg; 2006 Jul; 82(1):26-7. PubMed ID: 16798181
    [No Abstract]   [Full Text] [Related]  

  • 60. Portal vein thrombosis treated using danaparoid sodium and antithrombin III.
    Uchiyama T; Hirokazu T; Hosono K; Endo H; Akiyama T; Yoneda K; Inamori M; Abe Y; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2010; 57(97):52-3. PubMed ID: 20422871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.